{"id":12054,"date":"2026-09-11T14:26:21","date_gmt":"2026-09-11T14:26:21","guid":{"rendered":"https:\/\/www.musclestationth.com\/?p=12054"},"modified":"2026-09-11T14:26:21","modified_gmt":"2026-09-11T14:26:21","slug":"ll-37","status":"publish","type":"post","link":"https:\/\/www.musclestationth.com\/en\/ll-37\/","title":{"rendered":"LL-37: Wound research and evidence limits"},"content":{"rendered":"

LL-37 is a peptide studied in inflammation and wound healing. The existence of clinical research does not mean every LL-37 formulation has been tested or produces the same outcomes.<\/p>

What the research shows<\/h2>

The 2021 phase 2b HEAL LL-37 trial evaluated a topical preparation alongside compression therapy in 148 patients with difficult venous leg ulcers. The full-population analysis found no significant healing improvement versus placebo; subgroup observations should not become broad efficacy claims. [1]<\/a> [2]<\/a><\/p>

Distinguishing substances and products<\/h2>

The trial's topical preparation and an LL-37 vial require separate evidence. A description such as antimicrobial peptide is not itself proof that a product treats infection.<\/p>

Reading a specific brand\u2019s label<\/h3>

Start with the exact substance and product name, then match the label to the manufacturer\u2019s documents. This article does not establish Thai registration or current availability for an unspecified product.<\/p>

Frequently asked questions<\/h2>

Does the trial establish benefit for every wound?<\/h3>

No. It studied venous ulcers, and the overall efficacy analysis was not significantly better than placebo.<\/p>

Can topical evidence validate another vial presentation?<\/h3>

Only matching formulation evidence can support that comparison.<\/p>

What information helps identify a specific product?<\/h3>

The brand, product name, full label and matching manufacturer documents. Evidence about the substance alone does not establish a product\u2019s identity, registration or quality.<\/p>

Related information<\/h2>